Experience in treating molluscum contagiosum in children with imiquimod 5% cream

@article{Bayerl2003ExperienceIT,
  title={Experience in treating molluscum contagiosum in children with imiquimod 5\% cream},
  author={Christiane Bayerl and Gabriele Feller and Sergij Goerdt},
  journal={British Journal of Dermatology},
  year={2003},
  volume={149}
}
There is a wide variety of topical or surgical treatment options for molluscum contagiosum (MC). However, treatment in young or anxious children is difficult, time‐consuming and often painful. We studied the topical efficacy and tolerance of imiquimod, a topical immune‐response modifier, which stimulates the production of interferon‐αand other cytokines in children with MC. In an open‐label, follow‐up trial, imiquimod 5% cream was applied three times a week for 16 weeks to 15 children aged 4–11… Expand
Treatment of pediatric molluscum contagiosum with 10% potassium hydroxide solution
TLDR
Even though 10% KOH solution is associated with some local side effects, it is a safe, effective, inexpensive and noninvasive alternative treatment of MC in children. Expand
Molluscum contagiosum in paediatric patients: to treat or not to treat? Could a personalised Imiquimod regimen be the answer to the dilemma?
TLDR
Efficacy of this personalised treatment, scarce recurrence, absence of cicatricial sequelae and lack of necessity for deep sedation, in the case of children with disseminated lesions makes the use of Imiquimod the first line of treatment compared with other destructive treatments or with no-treatment at all. Expand
Molusco contagioso em crianças: tratamentos comparativos
TLDR
Treatment of this condition must be individualized, taking the patients’ preference, tolerance and availability of time into consideration, in efforts to customize the treatment approach. Expand
Molluscum contagiosum: A novel Ayurvedic approach
TLDR
The present study reports the efficacy of external application of Pratisaraṇīya Kṇāra (the type of Alkali used for smearing over the affected area) and Bilvādi Agada tablet orally in three cases, which yielded encouraging results. Expand
[Topical imiquimod for the treatment of anogenital warts in an infant].
TLDR
A ten-month-old infant was presenting large AW in the inguinal and perianal folds for a period of two months, which persisted despite one month of treatment with podophyllotoxin, and after a month of daily application of imiquimod, the AW was completely cured, with no recurrence at six months. Expand
A Prospective Randomized Trial Comparing the Efficacy and Adverse Effects of Four Recognized Treatments of Molluscum Contagiosum in Children
TLDR
It is believed that the ideal treatment for mollusca depends on the individual patient preference, fear, and financial status, distance from the office, and whether they have dermatitis or blood‐borne infections. Expand
How and when to treat molluscum contagiosum and warts in children.
TLDR
Recurrences of molluscum contagiosum and especially warts are common, and realistic expectations regarding the potential for treatment failure and recurrence should be discussed with the child and his or her family prior to initiating any therapy. Expand
Comparative Study on the Efficacy, Safety, and Acceptability of Imiquimod 5% Cream versus Cryotherapy for Molluscum Contagiosum in Children
TLDR
IMQ appears to be practically painless and more cosmetically accepted treatment when compared with cryotherapy, and may be the preferred treatment of MC in children especially with numerous small lesions. Expand
A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of Molluscum contagiosum in the pediatric age group
TLDR
10% KOH is an inexpensive and efficient modality for the treatment of MC in the pediatric age group and 5% imiquimod was effective in clearing the lesions with minimal adverse effects, but the longer duration required for its efficacy may deter its wider use. Expand
Interventions for cutaneous molluscum contagiosum.
TLDR
This is an update of a Cochrane Review to assess the effects of specific treatments and management strategies, including waiting for natural resolution, for cutaneous, non-genital molluscum contagiosum in people without immune deficiency. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Imiquimod Therapy for Molluscum Contagiosum
TLDR
Although topical imiquimod appears to have some efficacy in the therapy of MCV, in children the pruritus correlated relatively well with the development of new lesions, in adults, areas that would be expected to have better penetration appeared to respond more consistently. Expand
Self‐administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum
TLDR
Patient‐applied 5% imiquimod cream holds promise as an effective treatment of common warts and mollusca in a difficult‐to‐treat patient population. Expand
TOPICAL CIDOFOVIR FOR MOLLUSCUM CONTAGIOSUM IN CHILDREN
TLDR
After evaluating immunohistochemical and gene expression studies, these authors suggest that the lesions of LN and LP are likely to be mediated by T cells with antigen specificity distinct from those that cause erythema nodosum and intestinal lesions. Expand
Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir.
TLDR
Cidofovir, a nucleotide analog of deoxycytidine monophosphate, appears to have contributed to clearing of advanced MCV lesions in these 3 patients, thus providing suggestive evidence of clinical activity against MCV. Expand
Imiquimod in clinical practice.
  • L. Edwards
  • Medicine
  • The Australasian journal of dermatology
  • 1998
TLDR
When applied overnight at home three times each week, topical imiquimod 5% cream is an effective therapy with acceptable side-effects, and the recurrence rate is low. Expand
Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study.
TLDR
The 0.5% podophyllotoxin cream preparation was more efficacious than the 0.3% incorporation and can be considered a safe, home-based first line of therapy to cure molluscum contagiosum. Expand
Imiquimod: a novel treatment for lentigo maligna
Lentigo maligna is the in situ phase of lentigo maligna melanoma, and if left untreated it may progress to invasive melanoma. It most commonly occurs on the exposed sites of the face and neck ofExpand
Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream
TLDR
Active and control treatment groups were well matched for the number and duration of lesions and made a similar number of applications and found a 75% cure rate in the active treatment group and 21% cure with control treatment. Expand
Molluscum contagiosum in Human Immunodeficiency Virus Infection: Response to Zidovudine
TLDR
A 49-year-old homosexual man was diagnosed as having Croup III HIV infection (persistent generalised lymphadenopathy) in 1985 and within one week the patient was apyretic, in a good general condition, and a dramatic cutaneous improvement was observed. Expand
Imiquimod applied topically: A novel immune response modifier.
TLDR
Phase II clinical studies demonstrated efficacy in treating UV induced skin lesions, basal cell carcinoma, and actinic keratosis and in prevention of keloids after surgery. Expand
...
1
2
3
4
...